ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Jialun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7774-8517; OpenAlex author ID A5007013608. Sources: OpenAlex.

Their work

Papers: 5 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 5

CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma. Co-author DOI 10.1007/s13402-026-01165-x ↗
Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study. Co-author DOI 10.3390/biom16050685 ↗
Identification and validation of BCL11A as a neural and immune vulnerability factor in pancreatic adenocarcinoma. First author DOI 10.1016/j.bbadis.2025.167988 ↗
Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer. First author DOI 10.3390/cancers14215439 ↗
Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer. Co-author DOI 10.3390/cancers13184594 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Chen · 2 shared papers, 2021–2022 · strength 0.39
- Paper Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14215439 ↗
- Paper Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer. DOI 10.3390/cancers13184594 ↗
Jiajun Zhang · 1 shared paper, 2026 · strength 0.32
- Paper Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformati… DOI 10.3390/biom16050685 ↗
Ying Lv · 1 shared paper, 2026 · strength 0.32
- Paper Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformati… DOI 10.3390/biom16050685 ↗
Lei Wang · 1 shared paper, 2026 · strength 0.30
- Paper CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pan… DOI 10.1007/s13402-026-01165-x ↗
Aotian Chen · 1 shared paper, 2025 · strength 0.24
- Paper Identification and validation of BCL11A as a neural and immune vulnerability factor in pancreatic adenocarcinoma. DOI 10.1016/j.bbadis.2025.167988 ↗
Xiaoping Zou · 1 shared paper, 2025 · strength 0.24
- Paper Identification and validation of BCL11A as a neural and immune vulnerability factor in pancreatic adenocarcinoma. DOI 10.1016/j.bbadis.2025.167988 ↗
Xiaoping Zou · 1 shared paper, 2022 · strength 0.20
- Paper Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer. DOI 10.3390/cancers14215439 ↗
Xiaoping Zou · 1 shared paper, 2021 · strength 0.19
- Paper Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer. DOI 10.3390/cancers13184594 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.